Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

The heterogeneity of myelodysplastic syndromes (MDSs) has made evaluating patient response to treatment challenging. In 2006, the International Working Group (IWG) proposed a revision to previously published standardized response criteria (IWG 2000) for uniformly evaluating clinical responses in MDS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Platzbecker, U., Fenaux, P., Adès, L., Giagounidis, A., Santini, V., van de Loosdrecht, A. A., Bowen, D., de Witte, T., Garcia-Manero, G., Hellström-Lindberg, E., Germing, U., Stauder, R., Malcovati, L., Sekeres, Mikkael A., Steensma, David P., Gloaguen, S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2019
Assuntos:
Special Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042664/
https://ncbi.nlm.nih.gov/pubmed/30404811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-06-857102
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados